Source comparison
How to Use Sermorelin for Anti-Aging Protocol: Research-Grade Peptides Comparison
Sermorelin GHRH analogue. Stimulates pituitary GH release 8–12 minutes Once daily (before sleep) 20–35% increase from baseline Preserves endogenous GH pulsatility; lowest risk of receptor desensitisation CJC-1295 (DAC) Modified GHRH with drug affinity complex.
This comparison does not assign a generated winner or score.
- Sermorelin
- GHRH analogue. Stimulates pituitary GH release
- 8–12 minutes
- Once daily (before sleep)
- 20–35% increase from baseline
- Preserves endogenous GH pulsatility; lowest risk of receptor desensitisation
- CJC-1295 (DAC)
- Modified GHRH with drug affinity complex. Extended half-life
- 6–8 days
- Twice weekly
- 30–50% increase (sustained elevation)
- Longer dosing intervals but continuous GH elevation risks downregulation
- Ipamorelin
- GHRP. Ghrelin receptor agonist
- 2 hours
- 2–3 times daily
- 15–25% increase (synergistic with GHRH)
- Best used in combination with sermorelin for dual-axis stimulation
- MK-677
- Oral ghrelin mimetic
- 24 hours
- Once daily (oral)
- 40–60% increase (chronic elevation)
- Convenient oral dosing but chronic ghrelin signaling increases appetite and insulin resistance risk